The Horse

MAR 2019

The Horse:Your Guide To Equine Health Care provides monthly equine health care information to horse owners, breeders, veterinarians, barn/farm managers, trainer/riding instructors, and others involved in the hands-on care of the horse.

Issue link: https://thehorse.epubxp.com/i/1080930

Contents of this Issue

Navigation

Page 74 of 75

After 30 years, Adequan ® i.m. (polysulfated glycosaminoglycan) is still the only FDA-Approved equine intramuscular PSGAG prescription available. And still the only one proven to: 1, 2 Restore synovial joint lubrication Repair joint cartilage Reverse the disease cycle Reduce infl ammation Adequan ® i.m. actually treats degenerative joint disease, and not just the signs. Ask your veterinarian if Adequan ® i.m. is the right choice for your horse. Learn more at adequan.com. BRIEF SUMMARY: Prior to use please consult the product insert, a summary of which follows: CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. INDICATIONS: Adequan ® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. CONTRAINDICATIONS: There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. WARNINGS: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. PRECAUTIONS: The safe use of Adequan ® i.m. in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated. For customer care, or to obtain product information, visit www.adequan.com. To report an adverse event please contact American Regent, Inc. at (800) 734-9236 or email pv@americanregent.com. Please see Full Prescribing Information at www.adequan.com . 1 Adequan ® i.m. Package Insert, Rev 1/19. 2 Burba DJ, Collier MA, DeBault LE, Hanson-Painton O, Thompson HC, Holder CL: In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fl uid compartments and articular cartilage in an osteochondral defect model. J Equine Vet Sci 1993; 13: 696-703. Adequan and the Horse Head design are registered trademarks of American Regent, Inc. © 2019, American Regent, Inc. PP-AI-US-0214 02/2019 First of its kind. Still one of a kind.

Articles in this issue

Links on this page

Archives of this issue

view archives of The Horse - MAR 2019